journal article·2016-01Open access

Guided bone regeneration using resorbable membrane and different bone substitutes: Early histological and molecular events

Ibrahim Elgali, Alberto Turri, Wei Xia, Birgitta Norlindh, Anna Johansson, Christer Dahlin, Peter Thomsen, Omar Omar

Acta Biomaterialia· Volume 29

Abstract

Bone insufficiency remains a major challenge for bone-anchored implants. The combination of guided bone regeneration (GBR) and bone augmentation is an established procedure to restore the bone. However, a proper understanding of the interactions between the bone substitute and GBR membrane materials and the bone-healing environment is lacking. This study aimed to investigate the early events of bone healing and the cellular activities in response to a combination of GBR membrane and different calcium phosphate (CaP) materials. Defects were created in the trabecular region of rat femurs, and filled with deproteinized bovine bone (DBB), hydroxyapatite (HA) or strontium-doped HA (SrHA) or left empty (sham). All the defects were covered with an extracellular matrix membrane. Defects were harvested after 12h, 3d and 6d for histology/histomorphometry, immunohistochemistry and gene expression analyses. Histology revealed new bone, at 6d, in all the defects. Larger amount of bone was observed in the SrHA-filled defect. This was in parallel with the reduced expression of osteoclastic genes (CR and CatK) and the osteoblast-osteoclast coupling gene (RANKL) in the SrHA defects. Immunohistochemistry indicated fewer osteoclasts in the SrHA defects. The observations of CD68 and periostin-expressing cells in the membrane per se indicated that the membrane may contribute to the healing process in the defect. It is concluded that the bone-promoting effects of Sr in vivo are mediated by a reduction in catabolic and osteoblast-osteoclast coupling processes. The combination of a bioactive membrane and CaP bone substitute material doped with Sr may produce early synergistic effects during GBR. STATEMENT OF SIGNIFICANCE: The study provides novel molecular, cellular and structural evidence on the promotion of early bone regeneration in response to synthetic strontium-containing hydroxyapatite (SrHA) substitute, in combination with a resorbable, guided bone regeneration (GBR) membrane. The prevailing view, based mainly upon in vitro data, is that the beneficial effects of Sr are exerted by the stimulation of bone-forming cells (osteoblasts) and the inhibition of bone-resorbing cells (osteoclasts). In contrast, the present study demonstrates that the local effect of Sr in vivo is predominantly via the inhibition of osteoclast number and activity and the reduction of osteoblast-osteoclast coupling. This experimental data will form the basis for clinical studies, using this material as an interesting bone substitute for guided bone regeneration.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Bone Tissue Engineering Materials · Bone Metabolism and Diseases · Periodontal Regeneration and Treatments

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (56)

Show source-provided references
1. Clinical and histologic evaluation of allogeneic bone matrix versus autogenous bone chips associated with titanium-reinforced e-PTFE membrane for vertical ridge augmentation: a prospective pilot study
2. Sinus elevation with alloplasts or xenogenic materials and implants: an up-to-4-year clinical and radiologic follow-up
3. Healing of human extraction sockets filled with Bio-Oss10.1034/j.1600-0501.2003.140201.x ↗
4. Deproteinized bovine bone used as an adjunct to guided bone augmentation: an experimental study in the rat10.1111/j.1708-8208.2001.tb00136.x ↗
5. Ionic substitutions in calcium phosphates synthesized at low temperature10.1016/j.actbio.2009.12.041 ↗
6. In vivo anabolic effect of strontium on trabecular bone was associated with increased osteoblastogenesis of bone marrow stromal cells10.1002/jor.21127 ↗
7. Strontium enhances osteogenic differentiation of mesenchymal stem cells and in vivo bone formation by activating Wnt/catenin signaling10.1002/stem.646 ↗
8. Strontium potently inhibits mineralisation in bone-forming primary rat osteoblast cultures and reduces numbers of osteoclasts in mouse marrow cultures10.1007/s00198-014-2791-5 ↗
9. In vitro effects of S12911-2 on osteoclast function and bone marrow macrophage differentiation10.1016/S0014-2999(02)02040-X ↗
10. Dual effect of strontium ranelate: stimulation of osteoblast differentiation and inhibition of osteoclast formation and resorption in vitro10.1016/j.bone.2007.08.043 ↗
11. Molecular and structural patterns of bone regeneration in surgically created defects containing bone substitutes10.1016/j.biomaterials.2013.12.084 ↗
12. Periostin, a novel marker of intramembranous ossification, is expressed in fibrous dysplasia and in c-Fos-overexpressing bone lesions10.1016/j.humpath.2008.07.008 ↗
13. Strontium-doped calcium phosphate and hydroxyapatite granules promote different inflammatory and bone remodelling responses in normal and ovariectomised rats10.1371/journal.pone.0084932 ↗
14. Clinical, histologic and histomorphometric evaluation of socket preservation using a synthetic nanocrystalline hydroxyapatite in comparison with a bovine xenograft: a randomized clinical trial10.1111/j.1600-0501.2011.02288.x ↗
15. Comparison of osteogenic potential between apatite-coated poly(lactide-co-glycolide)/hydroxyapatite particulates and Bio-Oss10.4012/dmj.27.368 ↗
16. In vivo behaviour of low-temperature calcium-deficient hydroxyapatite: comparison with deproteinised bovine bone10.1007/s00264-010-1113-6 ↗
17. The molecular understanding of osteoclast differentiation10.1016/j.bone.2006.09.023 ↗
18. Biological responses to materials10.1146/annurev.matsci.31.1.81 ↗
19. Foreign body-type multinucleated giant cells induced by interleukin-4 express select lymphocyte co-stimulatory molecules and are phenotypically distinct from osteoclasts and dendritic cells10.1016/j.yexmp.2011.06.012 ↗
20. The characterization of macrophages and osteoclasts in tissues harvested from revised total hip prostheses10.1002/(SICI)1097-4636(1999)48:6<899::AID-JBM20>3.0.CO;2-E ↗
21. Multinucleated giant cells elicited around hydroxyapatite particles implanted in craniotomy defects are not osteoclasts10.1002/ar.1092420205 ↗
22. Synthetic bone substitute material comparable with xenogeneic material for bone tissue regeneration in oral cancer patients: first and preliminary histological, histomorphometrical and clinical results10.4103/2231-0746.119221 ↗
23. Influence of beta-tricalcium phosphate granule size and morphology on tissue reaction in vivo10.1016/j.actbio.2010.07.006 ↗
24. A new insight into the dissociating effect of strontium on bone resorption and formation10.1016/j.actbio.2011.02.013 ↗
25. A novel strontium(II)-modified calcium phosphate bone cement stimulates human-bone-marrow-derived mesenchymal stem cell proliferation and osteogenic differentiation in vitro10.1016/j.actbio.2013.07.027 ↗
26. Osteoblasts play key roles in the mechanisms of action of strontium ranelate10.1111/j.1476-5381.2009.00305.x ↗
27. Mg–Zr–Sr alloys as biodegradable implant materials10.1016/j.actbio.2012.04.028 ↗
28. Osteoblastic differentiation of stem cells from human exfoliated deciduous teeth induced by thermosensitive hydrogels with strontium phosphate10.1016/j.msec.2015.03.025 ↗
29. Strontium promotes osteogenic differentiation of mesenchymal stem cells through the Ras/MAPK signaling pathway10.1159/000204105 ↗
30. Strontium eluting graphene hybrid nanoparticles augment osteogenesis in a 3D tissue scaffold10.1039/C4NR05060F ↗
31. The osteogenic response of mesenchymal stromal cells to strontium-substituted bioactive glasses10.1002/term.2003 ↗
32. Strontium coating by electrochemical deposition improves implant osseointegration in osteopenic models10.3892/etm.2014.2038 ↗
33. Cancellous bone healing around strontium-doped hydroxyapatite in osteoporotic rats previously treated with zoledronic acid
34. Evaluation of injectable strontium-containing borate bioactive glass cement with enhanced osteogenic capacity in a critical-sized rabbit femoral condyle defect model10.1021/am507008z ↗
35. Periodontal regeneration using strontium-loaded mesoporous bioactive glass scaffolds in osteoporotic rats10.1371/journal.pone.0104527 ↗
36. Regeneration of rabbit calvarial defects using biphasic calcium phosphate and a strontium hydroxyapatite-containing collagen membrane
37. Characterization and in vivo evaluation of trace element-loaded implant surfaces in ovariectomized rats
38. Enhanced osseous implant fixation with strontium-substituted bioactive glass coating10.1089/ten.tea.2013.0304 ↗
39. Tissue-specific muscle, neural and liver stem/progenitor cells reside in the bone marrow, respond to an SDF-1 gradient and are mobilized into peripheral blood during stress and tissue injury10.1016/j.bcmd.2003.09.025 ↗
40. Conditional inactivation of the CXCR4 receptor in osteoprecursors reduces postnatal bone formation due to impaired osteoblast development10.1074/jbc.M111.250985 ↗
41. Stromal cell-derived factor-1 binding to its chemokine receptor CXCR4 on precursor cells promotes the chemotactic recruitment, development and survival of human osteoclasts10.1016/j.bone.2005.01.021 ↗
42. The effect of the physical characteristics of hydroxyapatite particles on human monocytes IL-18 production in vitro10.1016/j.biomaterials.2004.02.003 ↗
43. Effect of strontium-substituted biphasic calcium phosphate on inflammatory mediators production by human monocytes10.1016/j.actbio.2012.04.045 ↗
44. Strontium ranelate inhibits titanium-particle-induced osteolysis by restraining inflammatory osteoclastogenesis in vivo10.1016/j.actbio.2014.07.025 ↗
45. The inhibitory effect of strontium-doped calcium polyphosphate particles on cytokines from macrophages and osteoblasts leading to aseptic loosening in vitro10.1088/1748-6041/9/2/025010 ↗
46. Small intestinal submucosa: a substrate for in vitro cell growth10.1163/156856298X00208 ↗
47. Glycosaminoglycan content of small intestinal submucosa: a bioscaffold for tissue replacement10.1089/ten.1996.2.209 ↗
48. Effects of sterilization on an extracellular matrix scaffold: part I. Composition and matrix architecture10.1007/s10856-007-2300-x ↗
49. A. Turri, I. Elgali, F. Vazirisani, A. Johansson, L. Emanuelsson, C. Dahlin, et al., Guided bone regeneration is promoted by the molecular events in the membrane compartment. Submitted for Publication.
50. Selection and development of preclinical models in fracture-healing research10.2106/JBJS.G.01585 ↗
51. The rat model of femur fracture for bone and mineral research an improved description of expected comminution, quantity of soft callus and incidence of complications10.1302/2046-3758.28.2000171 ↗
52. Small animal bone healing models: standards, tips, and pitfalls results of a consensus meeting10.1016/j.bone.2011.07.007 ↗
53. Intracortical remodeling in adult rat long bones after fatigue loading10.1016/S8756-3282(98)00104-5 ↗
54. Monocyte subpopulations and their differentiation patterns during infection10.1189/jlb.0307191 ↗
55. Monocyte subsets in man and other species10.1016/j.cellimm.2014.03.019 ↗
56. Rodent models in bone-related research: the relevance of calvarial defects in the assessment of bone regeneration strategies10.1258/la.2010.010085 ↗